Reason for request
Re-assessment of Actual Benefit in compliance with article R. 163-21 of the French Social Security Code.
Clinical Benefit
| Insufficient |
The Committee considers that the actual benefit of AVANDIA and AVANDAMET products is now insufficient for it to be paid for by National Health Insurance, in comparison with existing therapies. |
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
r2njnL74n8cg9dZe
Listen
